Cargando…
Bridging infectious disease vaccines with cancer immunotherapy: a role for targeted RNA based immunotherapeutics
Tumor-specific immunotherapy holds the promise of eradicating malignant tumors with exquisite precision without additional toxicity to standard treatments. Cancer immunotherapy has conventionally relied on cell-mediated immunity while successful infectious disease vaccines have been shown to induce...
Autores principales: | Sayour, Elias J, Sanchez-Perez, Luis, Flores, Catherine, Mitchell, Duane A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404652/ https://www.ncbi.nlm.nih.gov/pubmed/25901285 http://dx.doi.org/10.1186/s40425-015-0058-0 |
Ejemplares similares
-
Cancer Vaccine Immunotherapy with RNA-Loaded Liposomes
por: Sayour, Elias J., et al.
Publicado: (2018) -
Immunotherapy for Pediatric Brain Tumors
por: Sayour, Elias J., et al.
Publicado: (2017) -
Manipulation of Innate and Adaptive Immunity through Cancer Vaccines
por: Sayour, Elias J., et al.
Publicado: (2017) -
The role of CMV in glioblastoma and implications for immunotherapeutic strategies
por: Rahman, Maryam, et al.
Publicado: (2018) -
Translational nanoparticle engineering for cancer vaccines
por: Grippin, Adam J., et al.
Publicado: (2017)